Dr. Emmanuel Mintah Bonku | Green Chemistry | Sustainable Chemistry Award

Dr. Emmanuel Mintah Bonku , Shanghai Institute of Materia Medica, CAS , China

Emmanuel Mintah Bonku, PhD, is a dedicated postdoctoral researcher at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, specializing in green chemistry and sustainable drug development. With a Ph.D. in Medicinal Chemistry from the University of Chinese Academy of Sciences, his research focuses on synthetic methodologies for antiviral drugs, especially in emerging diseases like monkey pox. He developed a groundbreaking synthesis process for tecovirimat, which is undergoing registration in China. Emmanuel has also worked on the synthesis of cariprazine, benzimidazole compounds, and other pharmaceuticals. His achievements have earned him the Excellent International Graduate Award from the Chinese Academy of Sciences in 2024. Passionate about sustainability in the pharmaceutical sector, Emmanuel strives to inspire future generations of scientists with his innovative approach to drug development.

Professional Profile:

Google Scholar

Orcid

Scopus 

Summary of Suitability for Award:

Emmanuel Mintah Bonku, PhD, is highly suitable for the “Sustainable Chemistry Award” based on his exceptional contributions to green and sustainable drug development, particularly in medicinal chemistry. His research focuses on the development of innovative and environmentally friendly synthetic methodologies, notably for antiviral and other life-saving drugs. He has demonstrated excellence in synthesizing antiviral drugs like tecovirimat for monkey pox, optimizing the production process for large-scale application with minimal environmental impact. Emmanuel Mintah Bonku has also worked on biotransformation techniques and green chemistry, striving to make pharmaceutical synthesis more sustainable. Emmanuel Mintah Bonku is an ideal candidate for the “Sustainable Chemistry Award” due to his groundbreaking work in green chemistry and sustainable pharmaceutical development. His innovative research and dedication to promoting sustainability in drug manufacturing make him a strong advocate for environmentally conscious chemistry practices.

🎓Education:

Emmanuel Mintah Bonku holds a Doctor of Philosophy (Ph.D.) in Medicinal Chemistry from the University of Chinese Academy of Sciences (2021-2024), focusing on green and sustainable drug development. He completed a Master of Engineering (M.Eg.) in Chemical Engineering and Technology from Wuhan University of Science and Technology (2018-2021), specializing in biotransformation and sustainable chemistry. Prior to that, he earned a Bachelor of Science (B.Sc.) in Environmental Science, with a focus on ethnobotany, from the University of Cape Coast, Ghana (2012-2017). In addition, Emmanuel holds a certificate in Information Communication and Technology (2012) from All Nations University College, Ghana. His academic background has equipped him with the technical expertise and interdisciplinary knowledge to make significant contributions to medicinal chemistry, particularly in the development of antiviral drugs and sustainable pharmaceutical processes.

🏢Work Experience:

Emmanuel Mintah Bonku is currently a postdoctoral researcher at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, specializing in sustainable drug development. During his doctoral research, he pioneered novel synthetic methodologies for antiviral drugs, contributing to the development of tecovirimat for monkeypox and cariprazine for schizophrenia. He has also worked extensively on the synthesis of benzimidazole compounds for antihypertensive and anthelmintic applications. In his earlier career, Emmanuel contributed to projects focused on biotransformation and sustainable chemistry while earning his Master’s degree at Wuhan University of Science and Technology. His experience spans academic research, guest reviewing for journals, and collaborative work with international experts in the field. Emmanuel’s role as a researcher involves advanced techniques in medicinal chemistry, drug synthesis, and process optimization, with an emphasis on green and sustainable practices.

🏅Awards: 

Emmanuel Mintah Bonku has been recognized for his outstanding contributions to medicinal chemistry, particularly in the synthesis of antiviral drugs. In 2024, he received the Excellent International Graduate Award from the Chinese Academy of Sciences in recognition of his innovative research on tecovirimat, a key antiviral drug for monkeypox. His achievements in sustainable drug development have positioned him as a leading figure in his field. Emmanuel has also contributed to various projects in the pharmaceutical industry and academia, promoting sustainability in drug development. His work has garnered attention and respect in the scientific community, and he continues to inspire others through his research, publications, and collaborations. As a guest reviewer for journals like Journal of Green Synthesis and Catalysis and Journal of Food Science, he is also recognized for his contributions to the scientific peer-review process. Emmanuel remains committed to advancing the field of green chemistry and pharmaceutical innovation.

🔬Research Focus: